Cellwise(SH:688325)2023-04-26 16:00Financial Performance - The company's operating revenue for Q1 2023 was ¥28,840,639.31, representing a decrease of 45.98% compared to the same period last year[5]. - The net profit attributable to shareholders was -¥1,592,793.74, a decline of 113.14% year-on-year[5]. - The net profit after deducting non-recurring gains and losses was -¥7,342,224.55, reflecting a decrease of 193.91%[6]. - Basic earnings per share were -¥0.0198, down 109.80% from the previous year[6]. - Total operating revenue for Q1 2023 was CNY 28,840,639.31, a decrease of 46.0% compared to CNY 53,387,601.51 in Q1 2022[19]. - Net profit for Q1 2023 was a loss of CNY 1,592,793.74, compared to a profit of CNY 12,120,298.90 in Q1 2022, indicating a significant decline in profitability[20]. - In Q1 2023, the company reported a total comprehensive loss of -1,579,209.39 RMB compared to a total comprehensive income of 12,124,021.38 RMB in Q1 2022[21]. - Basic earnings per share for Q1 2023 was -0.0198 RMB, a decrease from 0.2020 RMB in Q1 2022[21]. Research and Development - Total R&D investment amounted to ¥18,312,671.59, an increase of 29.37% year-on-year, accounting for 63.50% of operating revenue, up 36.99 percentage points[6]. - Research and development expenses increased to CNY 18,312,671.59 in Q1 2023, up from CNY 14,155,087.07 in Q1 2022, reflecting a growth of 29.8%[19]. - The company has not reported any significant new product developments or technological advancements during the quarter[16]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,698,045,568.12, a slight decrease of 0.16% from the end of the previous year[6]. - The total assets as of March 31, 2023, amounted to approximately CNY 1,043,323,919.98, a slight decrease from CNY 1,068,826,726.89 as of December 31, 2022[16]. - Total liabilities for Q1 2023 were CNY 48,504,117.54, a decrease from CNY 54,925,806.56 in Q1 2022, showing a reduction of 11.7%[18]. - The company's total equity increased to CNY 1,649,541,450.58 in Q1 2023, compared to CNY 1,645,894,443.88 in Q1 2022, reflecting a growth of 0.1%[19]. Cash Flow - The company reported a net cash flow from operating activities of -¥9,670,997.43, with no applicable comparison[6]. - Cash inflow from operating activities was 44,093,575.05 RMB, down from 54,485,193.31 RMB in the same period last year, representing a decline of approximately 19.5%[23]. - Cash outflow from operating activities totaled 53,764,572.48 RMB, compared to 76,486,810.02 RMB in Q1 2022, indicating a reduction of about 29.7%[24]. - The net cash flow from operating activities was -9,670,997.43 RMB, an improvement from -22,001,616.71 RMB in Q1 2022[24]. - The company recorded cash inflow from investment activities of 590,436,798.34 RMB, with a net cash outflow of -19,036,813.50 RMB from investment activities[25]. - Cash inflow from financing activities was 9,635,447.28 RMB, while cash outflow was 8,671,267.64 RMB, resulting in a net cash inflow of 964,179.64 RMB[25]. - The ending cash and cash equivalents balance was 1,032,061,201.38 RMB, down from 1,060,037,227.97 RMB at the beginning of the period[25]. - The company received 587,000,000.00 RMB from the recovery of investments during Q1 2023[24]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 9,394[12]. - The company reported a total of 17,610,600 shares held by Dongguan Weitu Investment, representing 21.56% of the total shares[14]. - The top shareholder, China Agricultural Bank, holds 1,042,628 shares, which is approximately 1.26% of the total shares[14]. Future Outlook and Strategy - The company experienced significant impacts on revenue due to uncertainties in the global economic outlook and a slowdown in domestic economic growth[10]. - The company has not provided specific future guidance or performance outlook for the upcoming quarters[16]. - The report indicates that there are no significant changes in the management or operational strategies during this period[16]. - The company plans to continue focusing on investment activities to enhance cash flow and overall financial health[26]. - There were no mergers or acquisitions reported in the first quarter of 2023[16].